Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l-Reference-Cited by-同舟云学术

Relative Efficacy of Atorvastatin 80 mg and Pravastatin 40 mg in Achieving the Dual Goals of Low-Density Lipoprotein Cholesterol <70 mg/dl and C-Reactive Protein <2 mg/l

Published:2005-05 Issue:10 Volume:45 Page:1644-1648
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Ridker Paul M.,Morrow David A.,Rose Lynda M.,Rifai Nader,Cannon Christopher P.,Braunwald Eugene

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines;Grundy;Circulation,2004

2. Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators;Ridker;Circulation,1999

3. Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study;Albert;JAMA,2001

4. Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events;Ridker;N Engl J Med,2001

5. Effect of hydroxymethyl glutaryl coenzyme A reductase inhibitor therapy on high sensitive C-reactive protein levels;Jialal;Circulation,2001

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Targeted Management of Inflammation In Atherosclerosis: A Narrative Review;Cardiology and Therapy;2024-07-20

2. Atherosclerosis and inflammation: Current therapeutic strategies. A review;Consilium Medicum;2024-05-02

3. Prevention of Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Persistent Low-grade In-flammation May be an Impediment Needing Attention;Indian Journal of Rheumatology;2024-02-25

4. Inflammation and Cardiovascular Outcomes;Contemporary Cardiology;2024

5. Anti-inflammatory Therapy for Cardiovascular Disease;Clinical Lipidology;2024